Laboratory of Epidemiology and Population Sciences, Intramural Research Program, National Institute on Aging, Bethesda, Maryland.
Department of Biostatistical Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina.
J Gerontol A Biol Sci Med Sci. 2014 Jun;69(6):751-8. doi: 10.1093/gerona/glt131. Epub 2013 Sep 7.
Diagnostic criteria for sarcopenia from appendicular lean mass (ALM), strength, and performance have been proposed, but little is known regarding the progression of sarcopenia. We examined the time course of sarcopenia and determinants of transitioning toward and away from sarcopenia.
ALM, gait speed, and grip strength were assessed seven times over 9 years in 2,928 initially well-functioning adults aged 70-79. Low ALM was defined as less than 7.95 kg/m(2) (men) or less than 6.24 kg/m(2) (women), low performance as gait speed less than 1.0 m/s, low strength as grip strength less than 30 kg (men) or less than 20 kg (women). Presarcopenia was defined as low ALM and sarcopenia as low ALM with low performance or low strength. Hidden Markov modeling was used to characterize states of ALM, strength, and performance and model transitions leading to sarcopenia and death. Determinants of transitioning toward and away from sarcopenia were examined with logistic regression.
Initially, 54% of participants had normal ALM, strength, and performance; 21% had presarcopenia; 5% had sarcopenia; and 20% had intermediate characteristics. Of participants with normal ALM, strength, and performance, 1% transitioned to presarcopenia and none transitioned to sarcopenia. The greatest transition to sarcopenia (7%) was in presarcopenic individuals. Low-functioning and sarcopenia states were more likely to lead to death (12% and 13%). Higher body mass index (p < .001) and pain (p = .05) predicted transition toward sarcopenia, whereas moderate activity predicted transition from presarcopenia to more normal states (p = .02).
Pain, physical activity, and body mass index, potentially modifiable factors, are determinants of transitions. Promotion of health approaching old age is important as few individuals transition away from their initial state.
已提出从四肢瘦体重(ALM)、力量和表现来诊断肌少症的标准,但对于肌少症的进展知之甚少。我们检查了肌少症的时间进程以及向肌少症发展和远离肌少症的转变的决定因素。
在 9 年内,对 2928 名年龄在 70-79 岁、最初功能良好的成年人进行了 7 次评估,评估内容包括 ALM、步行速度和握力。低 ALM 定义为男性<7.95kg/m(2)或女性<6.24kg/m(2),低表现定义为步行速度<1.0m/s,低力量定义为男性握力<30kg 或女性握力<20kg。前驱肌少症定义为低 ALM,肌少症定义为低 ALM 伴低表现或低力量。采用隐马尔可夫模型描述 ALM、力量和表现的状态,并建立导致肌少症和死亡的模型转变。采用逻辑回归检查向肌少症和远离肌少症转变的决定因素。
最初,54%的参与者具有正常的 ALM、力量和表现;21%的参与者存在前驱肌少症;5%的参与者存在肌少症;20%的参与者具有中间特征。在具有正常 ALM、力量和表现的参与者中,有 1%转变为前驱肌少症,没有参与者转变为肌少症。前驱肌少症患者向肌少症转变的比例最大(7%)。低功能和肌少症状态更有可能导致死亡(12%和 13%)。较高的身体质量指数(p<0.001)和疼痛(p=0.05)预测向肌少症转变,而中度活动预测从前驱肌少症向更正常状态的转变(p=0.02)。
疼痛、体力活动和身体质量指数是潜在可改变的因素,是转变的决定因素。在接近老年时促进健康很重要,因为很少有个体能从最初的状态转变。